Tacrolimus Extended-Release Capsules and Tivicay (Dolutegravir 25 mg and 50 mg)
Determining the interaction of Tacrolimus Extended-Release Capsules and Tivicay (Dolutegravir 25 mg and 50 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tacrolimus
Brand name: Astagraf XL, Envarsus XR, Prograf, Hecoria
Synonyms: Tacrolimus (oral and injection), Tacrolimus (Systemic)
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Tivicay
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tacrolimus Extended-Release Capsules-Tivorbex
- Tacrolimus Extended-Release Capsules-Tizanidine
- Tacrolimus Extended-Release Capsules-Tizanidine Capsules
- Tacrolimus Extended-Release Capsules-Tizanidine Hydrochloride
- Tacrolimus Extended-Release Capsules-TL Fluorivitamin
- Tacrolimus Extended-Release Capsules-TL Icon
- Tivicay (Dolutegravir 25 mg and 50 mg)-Tacrolimus Extended-Release Tablets
- Tivicay (Dolutegravir 25 mg and 50 mg)-Tacrolimus Granules for Suspension
- Tivicay (Dolutegravir 25 mg and 50 mg)-Tacrolimus Injection
- Tivicay (Dolutegravir 25 mg and 50 mg)-Tacrolimus Intravenous
- Tivicay (Dolutegravir 25 mg and 50 mg)-Tacrolimus oral and injection
- Tivicay (Dolutegravir 25 mg and 50 mg)-Tacrolimus Oral, Intravenous